Click on image to view larger version.

Fig. 2. GPC4 is required for early embryonic development. (A) The Gpc4Mo inhibits
translation of Gpc4 mRNA in vitro. Capped mRNA was in vitro
translated in the presence of increasing amounts (indicated in µg) of
Gpc4Mo (top panel) or CoMo (bottom panel). (B-D) Gpc4Mo specifically inhibits
translation of Gpc4 transcripts in vivo. (B) Embryos injected with
chimeric Gpc4GFP transcripts and CoMo. (C,D) Embryos injected with
Gpc4GFP mRNA and Gpc4Mo in one blastomere (arrow in C) or both
blastomeres (D). Injection of Gpc4Mo inhibits Gpc4GFP mRNA
translation as evidenced by lack of GFP activity. (E-J) Two-cell embryos were
injected with CoMo (E,G,I) or Gpc4Mo (F,H,J) and analysed at different
developmental stages. (E,F) GPC4 functions during gastrulation. Dorso-vegetal
view of stage 12 embryos. (E) Blastopore has closed in embryos injected with
CoMo (stage 12). (F) Blastopore remains open in embryos injected with Gpc4Mo
(stage 12). (G,H) GPC4 is required for anterior CNS development. Frontal view
of stage 21 embryos. Embryos injected with Gpc4Mo (H) retain an open anterior
neural tube (arrow) but develop a cement gland (arrowhead). (I,J) Side view of
tailbud stage embryos. In contrast to control embryos (I), embryos injected
with Gpc4Mo (J) are shorter, lack the dorsal fin and have small heads.
Arrowhead in J points to the missing dorsal fin; the arrow indicates
microcephaly. The developing eyes are encircled. CG, cement gland; Br, brain;
DF, dorsal fin.